Let’s never be unprepared for a health crisis.

Again.

Deploying infrastructure to protect society-critical
supply chains from deadly pathogens

Pilot Partnership

27.5%

Probability of a pandemic in the next decade equivalent in scale to covid-19

15 tn

Cost to society from the last pandemic
roughly equivalent to 5% of global GDP

6.7%

Annual increase in emerging infectious diseases driven by human activity

ABC during Covid-19

Up to 28% of total national capacity

The largest partner to the Swedish CDC

Research

Massive and rapid COVID-19 testing by extraction-free SARS-CoV-2 RT-PCR Tracking SARS-CoV-2 Mutations in Sweden SARS-CoV-2 Omicron BA.1/BA.2 lineage transition T-cell response to SARS-CoV-2 antigens after vaccination Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine Effects of a third dose SARS‑CoV‑2 BNT162b2 mRNA vaccine

Pathogen X

Securing society-critical supply chains with guaranteed
testing capacity, early detection, and real-time risk intelligence.

Pilot Partnership

WHO on future outbreaks and pandemics - identifying high-risk pathogens and preparing global response.

Lloyd's on human pandemic and the value of insurance.

Harvard on the inevitability of future pandemics — and the lack of preparedness.

The Lancet on the need for R&D and collaboration to get ahead of unknown pathogens.

The BMJ on likely pathogens and gaps in global response systems and scientific readiness.

Nature on that Europe needs to step up on epidemic preparedness - urgent reforms and leadership are lacking.

Johns Hopkins on Disease X - a proactive planning tool for future outbreaks.